Clinical Trial Update: Use of a Biodegradable Balloon for the Treatment of Prostate Cancer by Intensity Modulated Radiotherapy (BioPro-RCMI) [NA]

View source ↗

Summary

The BioPro-RCMI trial evaluating a biodegradable balloon to enhance intensity-modulated radiotherapy for prostate cancer has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Biodegradable balloon for radiotherapy (BioPro-RCMI)

Snippet

Sponsor: Centre Oscar Lambret | Conditions: Prostate Cancer | NA | Status: TERMINATED